Use of Antidepressants and Rates of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures

Diem, Susan J.·2007·Archives of Internal Medicine
DOI 10.1001/archinte.167.12.1240

Cited by (324)

Items 201–300 of 324

  1. Serotonin Rising
    George M. Anderson, Edwin H. Cook, Randy Blakely · 2009 · New England Journal of Medicine
  2. Neuronal Regulation of Bone Remodeling
    Florent Elefteriou, Gérard Karsenty · 2013 · Wiley eBooks
  3. Design, Synthesis, and Pharmacology of New Triazole-Containing Quinolinones as CNS Active Agents
    Wennan Zhao, Mingxia Song, Yi Hua, Yangnv Zhu, Wenli Liu, Qishan Xia, Xian‐Qing Deng, Yushan Huang · 2023 · Molecules
  4. Changes in volumetric BMD of radius and tibia upon antidepressant drug administration in young depressive patients.
    L Winterhalder, Prisca Eser, J Widmer, Peter Matthias Villiger, Daniel Aeberli · 2012 · PubMed
  5. Is there an association between the use of antidepressants and complications involving dental implants? A systematic review and meta-analysis
    Caio César Gonçalves Silva, Marcelo Soares dos Santos, João Luiz Gomes Carneiro Monteiro, Suzana Célia de Aguiar Soares Carneiro, Belmiro Cavalcanti do Egito Vasconcelos · 2020 · International Journal of Oral and Maxillofacial Surgery
  6. Wnt Proteins in Mineralized Tissue Development and Homeostasis
    Kevin A. Tompkins · 2011 · Connective Tissue Research
  7. Clinical Update on Nursing Home Medicine: 2013
    Barbara J. Messinger‐Rapport, Julie K. Gammack, David R. Thomas, John Edward Morley · 2013 · Journal of the American Medical Directors Association
  8. Predicting Bone Health Using Machine Learning in Patients undergoing Spinal Reconstruction Surgery
    Yong Shen, Zeeshan Mohammad Sardar, Herbert S Chase, Josephine Rose Coury, Meghan K. Cerpa, Lawrence G. Lenke · 2022 · Spine
  9. The Changes in Plasma Serotonin Levels after Hormone Therapy and Their Relationship with Estrogen Responsiveness on Bone in Postmenopausal Women
    Ha Young Kim, Mi Hyun Park, Hyun Koo Yoon, Ki Ok Han · 2012 · The Journal of Clinical Endocrinology & Metabolism
  10. Osteoporosis Piece of Multi‐Morbidity Puzzle in Geriatric Care
    Cathleen S Colon-Emeric, Mary Beth O’Connell, Elizabeth M Haney · 2011 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
  11. Effects of Drugs on Bone Quality
    Laurianne Imbert, Adele L. Boskey · 2016 · Clinical Reviews in Bone and Mineral Metabolism
  12. Serum serotonin concentration associated with bone mineral density in Chinese postmenopausal women
    Qiushi Wei, Zhenqiu Chen, Xin Tan, Kang Luchen, Xiaobing Jiang, Jiang Liang, Wei He, Weimin Deng · 2016 · Scandinavian Journal of Clinical and Laboratory Investigation
  13. Effects of treatment with fluoxetine on mandibular development: A morphological study in rats
    Priscylla Gonçalves Correia Leite de Marcelos, Luciana Silva Regueira, Isabela Maria Santiago-Jaegger, Danyel Elias da Cruz Pérez, Flávia Maria de Moraes Ramos‐Perez, Joaquim Evêncio‐Neto, Liriane Baratella‐Evêncio · 2015 · Acta Histochemica
  14. A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis
    Tammas Kelly · 2014 · Journal of Affective Disorders
  15. Predictors of falls and fractures leading to hospitalisation in 36 101 people with affective disorders: a large representative cohort study
    Ruimin Ma, Gayan Perera, Eugenia Romano, Davy Vancampfort, Ai Koyanagi, Robert J. Stewart, Christoph Mueller, Brendon Stubbs · 2022 · BMJ Open
  16. Antidepressant adverse drug reactions in older adults: Implications for RNs and APNs
    Amanda L. Mitsch · 2012 · Geriatric Nursing
  17. Depression and low bone mineral density: The correlation among Chinese
    Jaafer Mosadek Kurmanji, Syed Azhar Syed Sulaiman, Lau Kim Kah, Prem Kumar Chandrasekaran · 2010 · Asian Journal of Psychiatry
  18. Skeletal Effects of Drugs
    Juliet Elizabeth Compston · 2013 · Primer on the metabolic bone diseases and disorders of mineral metabolism
  19. Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy
    Jacyntha A. Sterling · 2007 · Hospital Pharmacy
  20. Depressive Disorders in Patients with Epilepsy: Underdiagnosed and Appropriately Managed?
    Alsaadi Taoufik · 2015 · Brain Disorders & Therapy
  21. Non-pharmacological and pharmacological treatments for bone health after stroke: Systematic review with meta-analysis
    Huixi Ouyang, Tsun C. Lee, Faye YF Chan, Xun Li, King Y. Lai, Wing Yan Lam, Tsz Y. Yung, Marco Y.C. Pang · 2024 · Annals of Physical and Rehabilitation Medicine
  22. Inhibition of peripheral serotonin synthesis by LP533401 and disturbances in calciotropic hormones attenuated excessive osteoblastogenesis with simultaneous improvement of bone mineral status in 5/6 nephrectomized rats
    Dariusz Pawlak, Tomasz Domaniewski, Beata Sieklucka, Magdalena Jakuc, Krystyna Pawlak · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  23. Antidepressant Treatment of Geriatric Depression
    Domenic A. Ciraulo, James A. Evans, Wei Qiao Qiu, Richard I. Shader, Carl Salzman · 2010 · Humana Press eBooks
  24. Psychopharmacology for Pain Medicine
    Mohammed Abdullah Issa, Zwade J. Marshall, Ajay D. Wasan · 2018 · Elsevier eBooks
  25. Patterns of psychoactive medication use in community-dwelling older adults in the US in 2016: a descriptive cross-sectional study
    Bajracharya, Rashmita, Qato, Danya M. · 2021 · Journal of Aging and Health
  26. Pharmacological Risk Assessment for Dental Implants
    Xixi Wu, Faleh Tamimi · 2018 · Springer eBooks
  27. Clinical Implications of Serotonin Regulation of Bone Mass
    Elizabeth M Haney, Chadi Albert Calarge, Michael M. Bliziotes · 2012 · Elsevier eBooks
  28. Effet des inhibiteurs sélectifs de recapture de la sérotonine (ISRS) sur la croissance osseuse : une revue de la littérature
    H. Kerbage, Sara Bahadori, Juliane Léger, J.-C. Carel, Diane Purper‐Ouakil · 2013 · L Encéphale
  29. Prospective Association Between the Dispensing of Antidepressants and of Medications to Treat Osteoporosis in Older Age
    Osvaldo P. Almeida, Amy Theresa Page, Frank Mario Sanfilippo, Christopher Etherton‐Beer · 2023 · American Journal of Geriatric Psychiatry
  30. Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?
    Samantha R. Weaver, Laura L. Hernandez · 2018 · Journal of Mammary Gland Biology and Neoplasia
  31. Los antidepresivos inhibidores selectivos de recaptura de serotonina (ISRS, ISR-5HT)
    Enrique Chávez-León, Martha Patricia Ontiveros Uribe, Carlos Serrano Gómez · 2008 · Salud Mental
  32. Non-estrogen-based treatments for menopausal symptoms
    Joan Pitkin, MARGARET C. P. REES, Sarah Gray, Mary Ann Lumsden, Jo Marsden, John C. Stevenson, Jennifer Williamson · 2008 · Menopause international
  33. Plasma serotonin and markers of bone formation and bone resorption in hemodialysis patients.
    Theodoros Eleftheriadis, Georgia Antoniadi, Vassilios Liakopoulos, Theodora Sparopoulou, Ioannis Stefanidis, Grammati Galaktidou · 2013 · Iranian Journal of Kidney Diseases
  34. Comparison of the effects of fluoxetine and venlafaxine on bone healing in a rat calvarial defect model
    Arif Sermed Erdem, Göksel Şimşek Kaya, Mahir Kaya, Büşra Altunay, Taha Yiğit Alkan, Havva Serap Toru · 2023 · Injury
  35. Endocrinology of bone/brain crosstalk
    Alessia Metozzi, Lorenzo Bonamassa, Gemma Brandi, Maria Luisa Brandi · 2015 · Expert Review of Endocrinology & Metabolism
  36. The expression and role of serotonin receptor 5HTR2A in canine osteoblasts and an osteosarcoma cell line
    Shay Bracha, Austin Keith Viall, Cheri P. Goodall, Bernadette V. Stang, Craig G. Ruaux, Bernard Séguin, Patrick Everett Chappell · 2013 · BMC Veterinary Research
  37. Effect of Moringa Oleifera on Bone Density in Post‐Menopausal Women
    Jason Brown, Edward Merritt, Chisimba N. Mowa, Steven R. McAnulty · 2016 · The FASEB Journal
  38. Wnt signaling, LRP5 and gut serotonin: Have we been targeting the right pathway for the wrong reasons?
    Roland Baron · 2009 · IBMS BoneKEy
  39. Secondary Osteoporosis
    Gregory R. Emkey · 2018 · Elsevier eBooks
  40. Secondary osteoporosis
    Gregory R. Emkey · 2024 · Elsevier eBooks
  41. Are selective serotonin reuptake inhibitors responsible for the failure of osseointegrated titanium-zirconium and one-piece zirconia dental implants in a premenopausal Caucasian woman? - A case report
    Pascal Grün, Florian Pfaffeneder‐Mantai, Benedikt Schneider, Patrick Bandura, Ann-Sophie Grün, Dritan Turhani · 2022 · Advances in Oral and Maxillofacial Surgery
  42. The Relationship of Serum Serotonin Levels to the Rate of Bone Loss and Fractures in Men
    Mee Kyoung Kim, Hyuk‐Sang Kwon, Ki‐Ho Song, Moo-Il Kang, Ki‐Hyun Baek · 2016 · Journal of Clinical Densitometry
  43. Association between depressive symptoms and bone density in elderly patients with non-dialysis dependent chronic kidney disease
    Dong-Young Lee, Dong Kyun Yoo, Sang Youb Han, Kangbaek Lee, Young Lee, Kayla M. Teopiz, Rodrigo Barbachan Mansur, Joshua Daniel Rosenblat, Roger S. McIntyre · 2022 · Journal of Affective Disorders
  44. Update on Hormone Replacement Therapy
    Camille Catherine Gunderson, Brad B. Swelstad, Howard A. Zacur · 2011 · Postgraduate Obstetrics & Gynecology
  45. A link between depression and bone metabolism: what are the implications for treatment?
    Briana R. Mezuk, Sherita Hill Golden · 2009 · Expert Review of Endocrinology & Metabolism
  46. Bone density and depression in premenopausal South African women: a pilot study
    Catherine Govender, Ame du Plessis, Priyesh Bipath, D Povey, G Viviers, M Viviers · 2010 · African Journal of Psychiatry
  47. Selective Serotonin Reuptake Inhibitors and Osteoporosis: Pathomechanism and Clinical Relevance Remain to Be Established
    Olaf Schulte‐Herbrüggen, Ion George Anghelescu · 2008 · Archives of Internal Medicine
  48. Recognition and Treatment of Late-LifeDepression
    James M. Ellison, Manjola Ujkaj · 2009 · Medical psychiatry
  49. Preoperative Antidepressants are Associated With Increased Risk of Opioid Use and Overall Complications Following Anterior and Posterior Cervical Fusion: A Nationwide Propensity-Matched Cohort Study
    Muhammad Abdul-Aziz Waheed, Mohammed Fawaz, Zina Smadi, Abdelrahman Diab, Omar Diab, Hamza Dyab, Ahmad N. Nassr, Ilyas S. Aleem, Rahul Vaidya · 2025 · Global Spine Journal
  50. Specific serotonin receptor antagonist reduces murine calcific atherosclerosis
    Andy Hon, Mimi Lu, Linda L. Demer, Yin Tintut · 2026 · Atherosclerosis
  51. Psychopharmaka im Alter
    Axel Wollmer, Franz Müller-Spahn · 2009 · Therapeutische Umschau
  52. Effects of LP533401 on vascular and bone calcification in hyperlipidemic mice
    Stuti Pradhan, Andy Hon, Yuxuan Xia, Sophia Kalanski, Nora Safvati, Mimi Lu, Linda L. Demer, Yin Tintut · 2024 · Biochemical and Biophysical Research Communications
  53. Overuse of benzodiazepines for anxiety disorders in older adults and cognitive decline: Which alternatives?
    Leonardo Massoni · 2024 · Aging and Health Research
  54. Survey of Osteoporosis in an Inpatient Geriatric Psychiatric Setting: A Pilot Study
    Ellen W. Blair, Bonnie L. Szarek, Naila Azhar · 2010 · Issues in Mental Health Nursing
  55. Osteoporosis secundaria a fármacos
    Meritxell Sallés, Saúl Mario Gelman · 2009 · Seminarios de la Fundación Española de Reumatología
  56. Bone mineral density in patients with depression
    Akın Erdal, Kadir Yıldırım, Saliha Karatay · 2007 · Journal of Back and Musculoskeletal Rehabilitation
  57. Evaluation of the link between chronic antipsychotic use and osteoporosis
    Rohini Downs, Monica L. Mathys · 2013 · Mental Health Clinician
  58. Antidepressiva
    Edith Holsboer‐Trachsler, Florian Holsboer · 2011 · Springer eBooks
  59. Acute periapical abscesses in patients using selective serotonin reuptake inhibitors
    Ilan Rotstein, Joseph Katz · 2022 · Special Care in Dentistry
  60. Bone mineral density response to antiosteoporotic drugs in older depressed adults
    Eyyüp Murat Efendioğlu, Ahmet Çiğiloğlu, Ercüment Öztürk, Zeynel Abidin Öztürk · 2023 · Archives of Osteoporosis
  61. Effect of Selective Serotonin Reuptake Inhibitor (Paroxetine) on Newly Formed Bone Volume: Real-Time In Vivo Micro–computed Tomographic Analysis
    Khalid Al Hezaimi, Ilan Rotstein, Joseph Katz, Marc L. Nevins, Myron Nevins · 2023 · Journal of Endodontics
  62. Pathophysiology and Epidemiology of Osteoporosis
    N. Stevens, S. Konda · 2020 · Springer eBooks
  63. Chapter 20. Psychopharmacology
    Benoit H. Mulsant, Bruce G. Pollock · 2022 · American Psychiatric Association Publishing eBooks
  64. Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors
    Raj A. Desai, Steven M. Smith, Rajesh Mohandas, Joshua David Brown, Haesuk Park · 2023 · Annals of Pharmacotherapy
  65. Medications for Mental Health Disorders and Impact on Bone
    Nigel L. Leslie-Allen, James M. Bolton, William Donald Leslie · 2024 · Springer eBooks
  66. Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology
    Peter Vestergaard · 2007 · Clinical Reviews in Bone and Mineral Metabolism
  67. Osteoporoza prouzrokovana lekovima
    Vojkan Nestorović, Julijana Rašić, Snezana Janićijević-Hudomal · 2013 · Биомедицинска истраживања
  68. Balancing bone health and mental health: a new clinical dilemma?
    Elizabeth M Haney · 2007 · Expert Review of Endocrinology & Metabolism
  69. Update on Medications With Adverse Skeletal Effects CONCISE REVIEW FOR CLINICIANS
    Caroline Jane Davidge-Pitts, Ann E. Kearns · 2011
  70. The Central Control of Bone Mass
    Shu Takeda · 2012 · Elsevier eBooks
  71. Antidepressants tested for everything from hot flashes to stroke
    Michelle F. Pflumm · 2011 · Nature Medicine
  72. Estimating the relationship between a transient effect and the onset of an acute event
    Carlin Brickner · 2015
  73. Effects on the skeleton from medications used to treat nonskeletal disorders
    Nelson B. Watts · 2020 · Elsevier eBooks
  74. Chapter 64. Skeletal Effects of Drugs
    Juliet Elizabeth Compston · 2008 · Primer on the metabolic bone diseases and disorders of mineral metabolism
  75. Secondary Causes of Osteoporosis: Other Medications
    Diane M. Biskobing · 2013
  76. Concerns About Bone Safety of Tricyclic Antidepressant Therapy—Reply
    2008 · Archives of Internal Medicine
  77. Concerns About Bone Safety of Tricyclic Antidepressant Therapy
    Wee Shiong Lim, Mark Y. Chan · 2008 · Archives of Internal Medicine
  78. Description and Prevalence of OCD in the Elderly
    Mary E. Dozier, Catherine R. Ayers · 2017
  79. Population-based studies on risk of fracture in patients with neurological disorders
    Sander Pouwels · 2014 · Utrecht University Repository (Utrecht University)
  80. Dietary modulation of uptake transporters
    Chiara Naccarati · 2014 · UPT. Syiah Kuala University Library (Syiah Kuala University)
  81. Role of Menopause-Related Factors and Depression in Cardiovascular Disease Risk and Bone Loss in Postmenopausal Minority Women with HIV: A Secondary Analysis
    Yamnia I. Cortés · 2015
  82. Eficacia de la calcitonina en la prevención de fracturas óseas osteoporóticas. Un metaanálisis
    María Sáinz-Gil · 2008
  83. La asociación psiquiátrica de América Latina
    Rodrigo Nel Cordoba Rojas · 2014 · Revista Colombiana de Psiquiatría
  84. Perte osseuse induite par les antidépresseurs et les neuroleptiques
    Véronique Breuil, Liana Euller‐Ziegler · 2011 · Revue du Rhumatisme Monographies
  85. Botdichtheid en gebruik van SSRI’s
    Teun van Gelder · 2008 · Medisch-Farmaceutische Mededelingen
  86. Le traitement hormonal de la menopause (THM) chez les jeunes medecins generalistes de Gironde : connaissances, attitudes et pratiques
    Paul Nalet · 2015 · HAL
  87. Antidepressants and Osteoporosis
    Sarah K. Rivelli, Andrew J. Muzyk · 2009 · Psychopharm Review
  88. Mood-Altering Drugs in the Trauma Population
    Diane T. Kupensky, Barbara M. Hileman, Elisha A. Chance, Susan L. Jones · 2013 · Journal of Trauma Nursing
  89. What We Know and What We Don’t: The Influence of Psychological Factors and Relationships on Medical Illness
    Tamara McClintock Greenberg · 2015 · Springer eBooks
  90. Was ist bei der Psychopharmakotherapie älterer Patienten zu beachten?
    Julian Deppe, Kai G. Kahl, Helge Frieling, Sermin Toto · 2014 · DNP - Der Neurologe und Psychiater
  91. Avaluació de la prevalença d’ús de medicaments en pacients que acudeixen a un servei d’urgències d’un hospital amb fractures per fragilitat òssia
    Gorgas Torner, M.A. Valero Queralt · 2016 · TDX (Tesis Doctorals en Xarxa)
  92. World Psychiatryis indexed in PubMed, Current Contents/Clinical Medicine, Current Contents/Social and Behavioral Sciences, Science Citation Index, and EMBASE Âñåìèðíàÿ Ïñèõèàòðè÷åñêàÿ Àññîöèàöèÿ (ÂÏÀ)
    Mario Maj, Èçáðàííûé Ïðåçèäåíò, Allan Tasman, Helen Herrman · 2011
  93. Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review
    Ana Padilla López, Ma José Moreno Fernández, Mercedes Jiménez‐Heredia, Vicent Savall Calabuig · 2017 · Drugs & Therapy Perspectives
  94. Knochenbrüche durch Opipramol?
    Nagia Ben Omar, Ekkehard Haen · 2017 · NeuroTransmitter
  95. Bone Disorders with Brain and Behavioral Conditions
    Christina V. Oleson, Tracy E. Ransom, Akinpelumi A. Beckley · 2017 · Springer eBooks
  96. CORR Insights®: Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision
    Emily Jane Woo · 2018 · Clinical Orthopaedics and Related Research
  97. Alcohol and Select Medications as Fall Risk Factors in Community Dwelling Older Adults in Canada
    Sarah Laberge · 2018 · UWSpace (University of Waterloo)
  98. Effects on the Skeleton from Medications Used to Treat Nonskeletal Disorders
    Nelson B. Watts · 2018 · Wiley eBooks
  99. Evaluación de la factibilidad de marcadores bioquímicos de recambio óseo en el pronóstico a largo plazo de la oseointegración
    Fabiana Lucía Galán · 2008
  100. Psychopharmacology for pain medicine
    James Celestin, Ajay D. Wasan · 2011 · Elsevier eBooks